254 related articles for article (PubMed ID: 36055392)
61. Transcriptome analysis reveals transmembrane targets on transplantable midbrain dopamine progenitors.
Bye CR; Jönsson ME; Björklund A; Parish CL; Thompson LH
Proc Natl Acad Sci U S A; 2015 Apr; 112(15):E1946-55. PubMed ID: 25775569
[TBL] [Abstract][Full Text] [Related]
62. Survival and integration of neurons derived from human embryonic stem cells in MPTP-lesioned primates.
Wakeman DR; Weiss S; Sladek JR; Elsworth JD; Bauereis B; Leranth C; Hurley PJ; Roth RH; Redmond DE
Cell Transplant; 2014; 23(8):981-94. PubMed ID: 23562290
[TBL] [Abstract][Full Text] [Related]
63. Therapeutic potential of pluripotent stem cell-derived dopaminergic progenitors in Parkinson's disease: a systematic review protocol.
Karimi A; Elmi M; Shiri Z; Baharvand H
Syst Rev; 2021 Jun; 10(1):188. PubMed ID: 34172098
[TBL] [Abstract][Full Text] [Related]
64. Co-transplantation of autologous T
Park TY; Jeon J; Lee N; Kim J; Song B; Kim JH; Lee SK; Liu D; Cha Y; Kim M; Leblanc P; Herrington TM; Carter BS; Schweitzer JS; Kim KS
Nature; 2023 Jul; 619(7970):606-615. PubMed ID: 37438521
[TBL] [Abstract][Full Text] [Related]
65. Meningeal cells influence midbrain development and the engraftment of dopamine progenitors in Parkinsonian mice.
Somaa FA; Bye CR; Thompson LH; Parish CL
Exp Neurol; 2015 May; 267():30-41. PubMed ID: 25708989
[TBL] [Abstract][Full Text] [Related]
66. A PITX3-EGFP Reporter Line Reveals Connectivity of Dopamine and Non-dopamine Neuronal Subtypes in Grafts Generated from Human Embryonic Stem Cells.
Niclis JC; Gantner CW; Hunt CPJ; Kauhausen JA; Durnall JC; Haynes JM; Pouton CW; Parish CL; Thompson LH
Stem Cell Reports; 2017 Sep; 9(3):868-882. PubMed ID: 28867345
[TBL] [Abstract][Full Text] [Related]
67. Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling.
Hu Z; Pu J; Jiang H; Zhong P; Qiu J; Li F; Wang X; Zhang B; Yan Z; Feng J
Stem Cells Dev; 2015 Nov; 24(21):2591-604. PubMed ID: 26218671
[TBL] [Abstract][Full Text] [Related]
68. Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease.
Kikuchi T; Morizane A; Doi D; Onoe H; Hayashi T; Kawasaki T; Saiki H; Miyamoto S; Takahashi J
J Parkinsons Dis; 2011; 1(4):395-412. PubMed ID: 23933658
[TBL] [Abstract][Full Text] [Related]
69. Expression of early developmental markers predicts the efficiency of embryonic stem cell differentiation into midbrain dopaminergic neurons.
Salti A; Nat R; Neto S; Puschban Z; Wenning G; Dechant G
Stem Cells Dev; 2013 Feb; 22(3):397-411. PubMed ID: 22889265
[TBL] [Abstract][Full Text] [Related]
70. Combining physical & cognitive training with iPSC-derived dopaminergic neuron transplantation promotes graft integration & better functional outcome in parkinsonian marmosets.
Daadi EW; Daadi ES; Oh T; Li M; Kim J; Daadi MM
Exp Neurol; 2024 Apr; 374():114694. PubMed ID: 38272159
[TBL] [Abstract][Full Text] [Related]
71. Induced dopaminergic neurons: A new promise for Parkinson's disease.
Xu Z; Chu X; Jiang H; Schilling H; Chen S; Feng J
Redox Biol; 2017 Apr; 11():606-612. PubMed ID: 28110217
[TBL] [Abstract][Full Text] [Related]
72. Autologous iPSC-derived dopamine neuron grafts show considerable promise in a nonhuman primate model of Parkinson's disease.
Wakeman DR
Mov Disord; 2015 Jul; 30(8):1034. PubMed ID: 26095814
[No Abstract] [Full Text] [Related]
73. Forced LMX1A expression induces dorsal neural fates and disrupts patterning of human embryonic stem cells into ventral midbrain dopaminergic neurons.
Rifes P; Kajtez J; Christiansen JR; Schörling A; Rathore GS; Wolf DA; Heuer A; Kirkeby A
Stem Cell Reports; 2024 Jun; 19(6):830-838. PubMed ID: 38759646
[TBL] [Abstract][Full Text] [Related]
74. Impaired motor coordination in Pitx3 overexpression mice.
Kim H; Quan X; Seong Y; Kim J
Biochem Biophys Res Commun; 2014 Apr; 446(4):1211-8. PubMed ID: 24680684
[TBL] [Abstract][Full Text] [Related]
75. Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's disease.
Park S; Park CW; Eom JH; Jo MY; Hur HJ; Choi SK; Lee JS; Nam ST; Jo KS; Oh YW; Lee J; Kim S; Kim DH; Park CY; Kim SJ; Lee HY; Cho MS; Kim DS; Kim DW
Cell Stem Cell; 2024 Jan; 31(1):25-38.e8. PubMed ID: 38086390
[TBL] [Abstract][Full Text] [Related]
76. Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.
Terpstra BT; Collier TJ; Marchionini DM; Levine ND; Paumier KL; Sortwell CE
J Neurosci Methods; 2007 Oct; 166(1):13-9. PubMed ID: 17706789
[TBL] [Abstract][Full Text] [Related]
77. Identification of Neurexophilin 3 as a Novel Supportive Factor for Survival of Induced Pluripotent Stem Cell-Derived Dopaminergic Progenitors.
Nishimura K; Murayama S; Takahashi J
Stem Cells Transl Med; 2015 Aug; 4(8):932-44. PubMed ID: 26041738
[TBL] [Abstract][Full Text] [Related]
78. Strategies for bringing stem cell-derived dopamine neurons to the clinic-The NYSTEM trial.
Studer L
Prog Brain Res; 2017; 230():191-212. PubMed ID: 28552229
[TBL] [Abstract][Full Text] [Related]
79. Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections.
Thompson L; Barraud P; Andersson E; Kirik D; Björklund A
J Neurosci; 2005 Jul; 25(27):6467-77. PubMed ID: 16000637
[TBL] [Abstract][Full Text] [Related]
80. Parkinson's disease in a dish - Using stem cells as a molecular tool.
Badger JL; Cordero-Llana O; Hartfield EM; Wade-Martins R
Neuropharmacology; 2014 Jan; 76 Pt A():88-96. PubMed ID: 24035919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
